Intrapleural bortezomib for the therapy of myelomatous pleural effusion: a case report
- PMID: 25374735
- PMCID: PMC4207597
- DOI: 10.1155/2012/978479
Intrapleural bortezomib for the therapy of myelomatous pleural effusion: a case report
Abstract
Myelomatous pleural effusion (MPE) is an extremely rare manifestation of multiple myeloma (MM). We present a case of MPE in a patient with IgG-κ MM treated with intrapleural bortezomib with systemic bortezomib-based therapy. Although we observed good local response, the patient succumbed due to systemic myeloma progression.
Figures
References
-
- Kintzer JS, Rosenow EC, Kyle RA. Thoracic and pulmonary abnormalities in multiple myeloma. A review of 958 cases. Archives of Internal Medicine. 1978;138(5):727–730. - PubMed
-
- Bataille R, Harousseau JL. Multiple myeloma. New England Journal of Medicine. 1997;336(23):1657–1665. - PubMed
-
- Rodriguez JN, Pereira A, Martinez JC, Conde J, Pujol E. Pleural effusion in multiple myeloma. Chest. 1994;105(2):622–624. - PubMed
LinkOut - more resources
Full Text Sources
